ロイタービデオ

次のビジネス (26 ビデオ)

    ビジネス

    GSK-Vir drug works against Omicron - data

    British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy developed with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies. Francis Maguire reports.